EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Single-cell transcriptomic analysis reveals the immunosuppressive status of NK cell subpopulations in TNBC

Yang Liu, Wen-Ming Cao, Ying Jin, Weizhen Xu iD

PLOS One · 2026

DOI: 10.1371/journal.pone.0354524 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Yang Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Trial, Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Killer Cells, Natural, Transcriptome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The talent revitalization and training funds from Zhejiang Cancer Hospital, Natural Science Foundation of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Triple-negative breast cancer (TNBC), lacking expression of the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), has clinical features that include high invasiveness, limited response to current immunotherapies, heightened risk of recurrence, and poorer overall prognosis. Central to these adverse clinical outcomes is the tumor microenvironment (TME), where the presence of immature natural killer (NK) cells with lower cytotoxic capacity has been associated with disease progression. Through a comprehensive analysis of publicly available single-cell transcriptomic data from breast cancer, we identified three NK cell subtypes within TNBC and non-TNBC tissues, named NK_XCL1, NK_FCGR3A, and NK_ISG15. Compared to non-TNBC, the presence and cytotoxic activity of NK_FCGR3A cells in TNBC were markedly diminished, primarily due to a substantial increase in the expression of inhibitory receptors like NKG2A (KLRC1). NK_ISG15 cells in TNBC show higher expression of type I interferon signaling genes. Through cell-type cross-talk analysis, we found that the feature of NK_FCGR3A cells in TNBC was mediated by myeloid cells with the HLA-E-KLRC1/HLA-E-CD94:NKG2A signal pathway. Notably, through integrating with public cancer transcriptomic data, we found higher expression of ISG15 is associated with poor prognosis, while higher expression of NK_FCGR3A signature genes is correlated with favorable prognosis. Collectively, these findings and the markers identified offer valuable insights into the mechanisms of immune evasion in TNBC, underscoring potential targets for developing therapeutic strategies that may improve patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsKiller Cells, NaturalTranscriptomeHumansFemaleSingle-Cell Gene Expression AnalysisSingle-Cell AnalysisTumor MicroenvironmentGene Expression ProfilingGene Expression Regulation, NeoplasticCell Line, TumorPrognosis

Autor:innen und Institutionen

  • Department of Clinical Trial, Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China.
  • Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, China.
  • Department of Breast Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China.

ORCID-Profile: Weizhen Xu

Förderung

  • The talent revitalization and training funds from Zhejiang Cancer Hospital
  • Natural Science Foundation of Zhejiang Province

Zitieren

APA

Liu, Y., Cao, W. M., Jin, Y., & Xu, W. (2026). Single-cell transcriptomic analysis reveals the immunosuppressive status of NK cell subpopulations in TNBC. PLOS One. https://doi.org/10.1371/journal.pone.0354524

Vancouver

Liu Y, Cao WM, Jin Y, Xu W. Single-cell transcriptomic analysis reveals the immunosuppressive status of NK cell subpopulations in TNBC. PLOS One. 2026. doi:10.1371/journal.pone.0354524

BibTeX
@article{Liu2026,
  author = {Liu, Yang and Cao, Wen-Ming and Jin, Ying and Xu, Weizhen},
  title = {Single-cell transcriptomic analysis reveals the immunosuppressive status of NK cell subpopulations in TNBC},
  journal = {PLOS One},
  year = {2026},
  doi = {10.1371/journal.pone.0354524}
}
Kostenlos starten →